Bicara Therapeutics BCAX
NASDAQ BCAX
$18.56 -0.24 (-1.28%)
At close: Sep 29, 2026 · 4:00 PM EDT

Bicara Therapeutics (BCAX) Operating Leases (2023 - 2026)

Updated

Bicara Therapeutics (BCAX) reported Operating Leases of $301,000 for Q1 2026, down 49.2% from the prior quarter.

Analysis

Bicara Therapeutics (BCAX) Operating Leases (2023 - 2026) Analysis & Trends

At the end of FY2025, Bicara Therapeutics posted Operating Leases of $593,000, up 352.7% from FY2024.

  • By year, Operating Leases came in at $131,000 in FY2024 (-64.8%) and $372,000 in FY2023.
  • The Q1 2026 figure ranks as the lowest quarterly Operating Leases since Q4 2024.
  • Per Business Quant data, the three quarters before Q1 2026 came in at $593,000 (Q4 2025), $880,000 (Q3 2025) and $1.16 million (Q2 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn
10 Bicara Therapeutics 1.24 Bn 1.24 Bn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 301,000.00
Dec 31, 2025 593,000.00
Sep 30, 2025 880,000.00
Jun 30, 2025 1.16 Mn
Dec 31, 2024 131,000.00
Sep 30, 2024 137,000.00
Dec 31, 2023 372,000.00
API Access

Bicara Therapeutics Operating Leases API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=operating-leases&ticker=BCAX&period=max&api_key=YOUR_API_KEY